L
Lauren J. Stockman
Researcher at Centers for Disease Control and Prevention
Publications - 28
Citations - 3157
Lauren J. Stockman is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Virus & Population. The author has an hindex of 21, co-authored 28 publications receiving 2873 citations. Previous affiliations of Lauren J. Stockman include National Center for Immunization and Respiratory Diseases & United States Department of Veterans Affairs.
Papers
More filters
Journal ArticleDOI
SARS: Systematic Review of Treatment Effects
TL;DR: It was not possible to determine whether treatments benefited patients during the SARS outbreak, but clinical trials should be designed to validate a standard protocol for dosage and timing and to accrue data in real time during future outbreaks to monitor specific adverse effects and help inform treatment.
Journal ArticleDOI
Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006.
TL;DR: Respiratory syncytial virus hospitalization rates remained steady during 1997 to 2006 and were a substantial burden in the United States, especially among infants and young children.
Journal ArticleDOI
Direct healthcare costs of selected diseases primarily or partially transmitted by water.
Sarah A. Collier,Lauren J. Stockman,Lauri A. Hicks,Laurel E Garrison,F. J. Zhou,Michael J. Beach +5 more
TL;DR: The five primarily waterborne diseases in this analysis were responsible for over 40 000 hospitalizations at a cost of $970 million per year, including at least $430 million in hospitalization costs for Medicaid and Medicare patients.
Journal ArticleDOI
WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus
Holger J. Schünemann,Suzanne Hill,Meetali Kakad,Richard Bellamy,Timothy M. Uyeki,Frederick G. Hayden,Yazdan Yazdanpanah,John H. Beigel,Tawee Chotpitayasunondh,Chris Del Mar,Jeremy Farrar,Tran Tinh Hien,Bülent Özbay,Norio Sugaya,Keiji Fukuda,Nikki Shindo,Lauren J. Stockman,Gunn Elisabeth Vist,Alice Croisier,Azim Nagjdaliyev,Cathy Roth,Gail Thomson,Howard Zucker,Andrew D Oxman +23 more
TL;DR: A strong recommendation to treat H5N1 patients with oseltamivir was made in part because of the severity of the disease, and strong recommendations were made to use neuraminidase inhibitors as chemoprophylaxis in high-risk exposure populations.
Journal ArticleDOI
Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States.
Daniel C. Payne,Mary Allen Staat,Kathryn M. Edwards,Peter G. Szilagyi,Jon R. Gentsch,Lauren J. Stockman,Aaron T. Curns,Marie R. Griffin,Geoffrey A. Weinberg,Caroline B. Hall,Gerry Fairbrother,James P. Alexander,Umesh D. Parashar +12 more
TL;DR: The rotavirus detection rate was 50% for hospitalized acute gastroenteritis cases, 50 % for emergency department visits, and 27% for outpatient visits in the US.